Monday morning, Scotiabank announced the exchange of its operations in Colombia, Costa Rica and Panama for a 20% stake in Davivienda, Colombia's second largest bank. The transaction is expected to close in 12 months, subject to regulatory approvals.
National Bank notes that a 20% stake in Davivienda is worth $600 million, which compares to the ~$1 billion Scotiabank paid to acquire its 51% stake in the Colombian operation in 2012 and the US$360 million it paid for its banking operations in Panama and Costa Rica in 2016 from Citibank. As a result, Scotiabank is recording around a $1.4 billion impairment charge during the first quarter.
Analyst Gabriel Dechaine has a constructive view of this transaction. "Colombia, in particular, had been a drag on BNS' bottom line for several years," he notes. Although no timeline has been provided, Dechaine believes the 20% Davivienda stake could be more profitable to Scotiabank than its current position is, considering that its new partner has existing operations in these three countries that should allow it to extract expense synergies.
The transaction is neutral to Scotiabank's CET 1 ratio, with a hit of 10-15bps from the impairment loss offset by a 10-15bps boost from the reduction of risk-weighted assets.
Scotiabank is rated Sector Perform, with a $78 target.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.